Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Operating Expenses | 6,776 | 7,609 | 5,535 | 5,749 | 5,115 |
| Operating Income | -6,776 | -7,609 | -5,535 | -5,749 | -5,115 |
| Interest Expense | 154 | 191 | 191 | 189 | 184 |
| Other Income | 4,602 | -4,922 | -235 | 2,766 | -4,763 |
| Pre-tax Income | -2,328 | -12,722 | -5,961 | -3,172 | -10,062 |
| Net Income Continuous | -2,328 | -12,722 | -5,961 | -3,172 | -10,062 |
| Net Income | $-2,328 | $-12,722 | $-5,961 | $-3,172 | $-10,062 |
| EPS Basic Total Ops | -0.15 | -0.87 | -0.44 | -0.32 | -1.02 |
| EPS Basic Continuous Ops | -0.15 | -0.87 | -0.44 | -0.32 | -1.02 |
| EPS Diluted Total Ops | -0.44 | -0.63 | -0.44 | -0.56 | -1.02 |
| EPS Diluted Continuous Ops | -0.15 | -0.88 | -0.44 | -0.30 | -1.02 |
| EBITDA(a) | $-6,603 | $-7,440 | $-5,419 | $-5,637 | $-5,041 |